Cannabidiol with CBT for generalized anxiety
About this title
Read the official source — NCT07123467Understand this study
Who could participate?
Listed age limits: 18 years to 45 years.
What will I do during this study?
You receive a five-week course of brief cognitive behavioural therapy. Depending on your randomly assigned group, this is combined with a lower or moderate dose of oral cannabidiol (EPIDIOLEX) or a matching inactive placebo solution.
- Listed locations
- DetroitSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 90
- Sponsor
- Wayne State University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 45 Years
- Official registry ID
- NCT07123467
- Official title
Show the full official title
Cannabidiol-Enhanced Cognitive Behavioral Therapy for Generalized Anxiety Disorder
Recruitment & locations
Detroit
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Wayne State University, a university.
Does this study involve medication?
Yes. The study involves medication, including Low-Dose Cannabidiol, Placebo Matched to Moderate-Dose Cannabidiol, Moderate-Dose Cannabidiol and Placebo Matched to Low-Dose Cannabidiol.
Who can participate?
Listed age limits: 18 years to 45 years.
Is this study still recruiting?
The registry lists this study as recruiting.
